報價延遲最少15分鐘:2025/07/07 00:42 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
84.39 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
1.97/2.47
|
|
企業價值
2.08B
|
| 資產負債 |
|
每股賬面淨值
15.38
|
| 現金流量 |
|
現金流量率
0.03
|
| 損益表 |
|
收益
219.86M
|
|
每股收益
8.21
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/07 00:42 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients. |